Gregory Russotti
Chief Technology & Manufacturing OfficerDr. Gregory Russotti, also known as Greg, Ph.D., serves as its Chief Technology and Manufacturing Officer at Century Therapeutics, Inc. since December 04, 2023. Dr. Russotti served as Interim President & Chief Executive Officer at Century Therapeutics, Inc. since April 11, 2023 until December 04, 2023 and served as its Chief Technology Officer since January 2020 until April 11, 2023. Dr. Russotti member of the National Science Foundation-funded Center for the Manufacturing of Advanced Therapeutics at Georgia Tech and serves on the scientific advisory board for Dynamk Capital. Dr. Russotti held multiple positions at Celgene Corporation, a Bristol Myers Squibb company, from 2006 until 2009, including, Vice President of Cell Therapy Technical Development from January 2018 to November 2019, Vice President of Cell Therapy Development and Operations from October 2016 to December 2017, Vice President of Technical Operations of Celgene Cellular Therapeutics from May 2013 to October 2016 and Executive Director of Technical Operations of Celgene Cellular Therapeutics from June 2011 to May 2013. He was Industry and Practitioner Advisory Board Member at NSF Engineering Research Center for Cell Manufacturing Technologies until June 2024. Prior to this, Dr. Russotti served as Senior Investigator at Merck & Co., where he oversaw process development of vaccines and biologics from December 2004 to November 2006 and various positions of increasing responsibility dating back to 1991, when he began his career at Merck. Dr. Russotti holds a number of honors including the ECI and NIIMBL Cell Therapy Manufacturing Award for leadership in cell therapy process development, scale-up and manufacturing in 2019 as well as receiving the Rutgers Engineering School Distinguished Alumnus Medal of Excellence in Education and Research in 2013 and the John W. Jackson Leadership Award in 2011, an award that was given to one leader at Celgene each year. Dr. Russotti holds both a B.S. and M.S. in chemical engineering from Rensselaer Polytechnic Institute. He received his Ph.D. in biochemical and chemical engineering from Rutgers University.
Positions
- Company NameCentury Therapeutics, Inc.Stock CodeIPSCPositionChief Technology & Manufacturing OfficerColleagues
- BPBrent PfeiffenbergerPresident, CEO & Chairman
- CAChad A. CowanChief Scientific Officer
- DCDouglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary
- KKKrista KauppinenVP, General Counsel & Head of Intellectual Property
- KLKimberly Lynn BlackwellLead Independent Director
- DEDaphne E. QuimiIndependent Director
- MPMartin Patrick MurphyIndependent Director
- JJJoseph JimenezSpecial Advisor to the Board
